This AI-driven platform revolutionizes how construction and infrastructure projects are managed by transforming vast, unstructured project data into actionable intelligence. Built upon a large language model (LLM) trained on domain-specific data including regulatory requirements, contract documents, project schedules, communication logs, digital drawings, and specifications, the technology provides real-time insights and foresight across project lifecycles. It detects risks, predicts cost and schedule deviations, and highlights potential regulatory non-compliance before they escalate into major issues. By integrating across existing tools and data sources such as Microsoft Teams, WhatsApp, SharePoint, and email systems, the AI engine enables project stakeholders to make informed decisions through a single intelligent interface. Ideal collaboration partners include real estate developers, construction contractors, architecture and engineering consultants, and AI software integrators seeking to augment project performance through predictive analytics and knowledge automation.

While split-thickness autograft (STSG) combined with dermal substitutes remains the conventional procedure for burn wounds, evolving advancement in technologies have provided alternatives and multi-model treatment for deep burns which includes mechanisms such as dermal scaffolds, cellular therapies, anti-microbial dressings and regenerative adjuncts. This technology introduces a topical burn treatment formulated with Transition Metal Dichalcogenide (TMD), WS2 (tungsten disulfide) nanosheets as the key active ingredient. TMDs are a class of two-dimensional (2D) layered materials combining tunable electronic, optical, and catalytic properties with excellent mechanical flexibility and chemical stability. Traditional burn therapies mainly focus on anti-bacterial activity but often delay healing due to strong cytotoxicity. The TMD nanosheet formulation shows powerful anti-oxidant, anti-inflammatory, and anti-bacterial effects simultaneously. It efficiently scavenges reactive oxygen and nitrogen species (ROS/RNS), suppresses inflammatory cytokines, and reduces cell apoptosis—ultimately minimizing tissue damage and promoting faster wound recovery. These attributes make TMDs promising for next-generation biomedical materials, particularly in antibacterial coatings, wound dressings, and photothermal therapy—offering multi-functionality beyond traditional metallic or polymeric materials. Laboratory and animal studies have verified its efficacy and safety, suggesting strong potential for clinical translation once large-scale synthesis and formulation optimization are completed. The technology owner is seeking collaboration partners with:  Pharmaceutical and skincare companies Medical material manufacturers Clinical research institutions interested in nanomaterial-based drug delivery systems and topical wound-care products.

Speech and voice disorders can significantly affect a person’s ability to communicate and engage with others, especially during childhood development. While special education schools provide valuable support within their premises, there remains a critical need for tools that empower individuals to communicate more confidently in everyday environments. This assistive communication technology bridges that gap. It combines both hardware and software to help users, primarily children under 12, though suitable for anyone who requires speech assistance to express themselves more clearly. Importantly, the device is not meant to replace natural speech but to supplement it, providing users with an additional way to articulate words or phrases that may be difficult to pronounce. In doing so, it supports inclusive communication and helps individuals build confidence in social interactions. This technology can be deployed in collaboration with special education institutions, medical device manufacturers, and software developers focusing on speech therapy and assistive technologies.

Conventional lightweighting materials often face an inherent trade-off between structural integrity, weight reduction, and multifunctionality. Common composites and polymer foams achieve lower weight but typically compromise on mechanical robustness, acoustic absorption, or electromagnetic compatibility—limitations that constrain energy efficiency, payload optimization, and system reliability in next-generation aerospace and urban air mobility platforms. This technology introduces a new class of ultra-lightweight functional materials with densities below 10 mg/cm³, offering a combination of extreme lightness, tuneable multifunctionality, and structural stability. By combining extreme lightness with multifunctionality, it addresses critical challenges in industries such as aerospace, urban air mobility, and advanced electronics. Key applications of these materials include noise reduction through sound-absorbing materials for drones, eVTOLs, and aircraft; lightweight electromagnetic shielding and wave absorption for aerospace and communication systems; and thermal management solutions, including insulation materials for aircraft, that enhance energy efficiency and operational safety. The technology owner is interested to work with aerospace, mobility, or electronics manufacturers on joint R&D projects, prototyping and test-bedding opportunities to commercialise the next-generation of lightweight materials.

Conventional photovoltaic (PV) panels face key limitations in efficiency, design flexibility, and sustainability. Though widely adopted, crystalline silicon modules are heavy, visually intrusive, and perform poorly under shading or high-temperature conditions. Their installation is typically restricted to rooftops, limiting energy yield in space-constrained urban environments. Moreover, silicon-based PV manufacturing involves energy-intensive processes and carbon emissions that run counter to the goals of green construction. This thin-film cadmium telluride (CdTe) solar glass technology overcomes the limitations of conventional photovoltaics by integrating photovoltaic elements into glass for building-integrated photovoltaics (BIPV) applications. It effectively addresses high energy consumption and carbon emissions in modern buildings while maintaining architectural aesthetics. Achieving a conversion efficiency of 22.1% under laboratory conditions, the CdTe solar glass delivers outstanding low-light and temperature performance, ensuring reliable energy generation across diverse environments. The design is highly customizable for seamless integration with glass, stone, or aluminum façades—supporting applications such as curtain walls, sunshades, skylights, and other façade elements. By generating clean energy without compromising transparency or design versatility, the technology offers a practical pathway toward energy-efficient, low-carbon urban development, helping stakeholders meet green building and ESG objectives. The technology owner is seeking collaboration with Singapore-based building material manufacturers, glass processors and architectural firms to jointly advance the integration of sustainable energy technologies into urban infrastructure, supporting Singapore’s transition toward low-carbon, energy-efficient buildings.

The Arm Booster is a rehabilitation device designed for stroke patients and individuals with arm muscle weakness. It employs a symmetrical-reflex mechanical mechanism, allowing the stronger arm to support and stimulate the weaker arm. Equipped with force and motion sensors, the device records real-time performance data that can be monitored and analyzed through dedicated software. Integrated gamification features further enhance patient motivation by turning repetitive exercises into engaging, interactive tasks. The system is lightweight, safe, cost-effective, and suitable for use in hospitals, rehabilitation centers, elderly care facilities, and potentially in home-based settings. The ideal collaboration models for the Arm Booster include research and development partnerships with medical and engineering institutions to further advance its technical capabilities. In parallel, licensing agreements with established medical device manufacturers can facilitate large-scale production and distribution. Additionally, collaborations with healthcare organizations and HealthTech companies could accelerate commercialization and drive expansion into new markets, such as digital health and home-based rehabilitation solutions. The device is competitively priced for sale or rental locally, and open to flexible business models with overseas partners.

In today’s data-driven world, companies manage vast volumes of information scattered across multiple systems, formats, and repositories. However, these data assets often remain underutilized due to inconsistency, fragmentation, and lack of accessibility. This Accelerated Retrieval-Augmented Generation (RAG) System Design enables organizations to rapidly develop customized Generative AI (GenAI) solutions that securely retrieve and process information from complex document sets. The solution facilitates seamless knowledge access while ensuring data privacy and eliminating the risk of data leakage. Built for flexibility, the system can be adapted across industries and document types — from legal and financial records to technical documentation and enterprise resource planning (ERP) data — allowing organizations to unlock insights from their internal data faster and more accurately than ever before.

Coronary artery disease (CAD) is the leading cause of death worldwide. Computed Tomography Coronary Angiography (CTCA), as a non-invasive alternative to invasive catheterized coronary angiography, has emerged as a recommended first-line investigation for CAD. However, the current practice of generating reports involves a time-intensive process, with CT specialists spending 3-6 hours annotating scans. Furthermore, there is a lack of effective tools for analysing coronary calcium scores, stenosis severity, and plaque characterization. This AI driven platform is for CT data processing that provides a streamlined 'one-stop' solution spanning from diagnosis to clinical management and prognosis. Its key features include: AI-driven platform for CTCA, catering to clinical, research, and industrial applications. Large, shareable, de-identified, Personal Data Protection Act-compliant real-world CT data. Precision toolkits for anonymization, coronary calcium scoring, epicardial adipose tissue (EAT), stenosis severity assessment, plaque quantification, CT fractional flow reserve (FFR), and reporting. The platform’s highly automated features assist physicians in interpreting and synthesizing large volumes of CT data, while minimizing bias, increasing reproducibility, and providing numerical insights in a graphical manner. It offers a comprehensive ‘one-stop’ solution for diagnosis and clinical management of CAD.

Polyoxymethylene (POM) is a high-performance engineered thermoplastic widely used in the automotive, electronics, and industrial sectors due to its excellent mechanical strength, chemical resistance, and dimensional stability. However, its conventional production relies heavily on formaldehyde derived from fossil-based methanol, presenting significant sustainability and carbon footprint challenges. Amid growing environmental concerns and global net-zero commitments, carbon dioxide (CO₂) utilisation is emerging as a promising approach for transforming waste carbon into value-added materials. Among various CO₂-derived chemicals, methanol stands out as a viable and sustainable feedstock, offering a low-carbon alternative to traditional petrochemical-based inputs. To advance circular economy goals and reduce reliance on fossil resources, a Singapore-based SME is seeking innovative and scalable technologies that can convert CO₂-derived methanol into POM or its intermediates such as formaldehyde or trioxane. Proposed solutions may include end-to-end pathways using commercially viable CO₂-derived methanol to produce POM, or novel routes that directly convert CO₂ into POM through intermediate steps.

In 2023, Singapore generated approximately 755,000 tonnes of food waste, with only 18% recycled, underscoring the urgent need for innovative waste management strategies. The nation's Zero Waste Master Plan have significantly propelled efforts to transform food waste into valuable resources. Food waste valorisation involves pre-processing steps like drying, microbial fermentation, or enzymatic breakdown into biomass which can convert nutrients into suitable ingredients for animal feed, food ingredients and biofuels.  A significant technical challenge arises for companies handling heterogeneous municipal food waste in Singapore due to its high oil content. The presence of oil may potentially lead to fouling, clogging of processing equipment, reducing processing efficiency. On the contrary, oil is also a valuable ingredient for biofuel. Therefore, the company is seeking for solution providers who can de-oil from the biomass.

According to the Health Promotion Board (HPB) in Singapore, 90% of Singapore residents' consumption of sodium exceeds the daily recommended intake, with the average consumption at 3620 mg, nearly double of the recommended 2000 mg per day. As a result, one in six Singapore residents report health problems like hypertension and hypolipidaemia. In an effort to curb this, HPB launched the "Less Salt, More Taste" campaign in 2024 to encourage the food manufacturing and food service industry to change their recipes and add less salt and sauces, or switch to use lower-sodium alternatives for salt, sauces and seasonings. Manufacturers are also encouraged to increase the supply of lower-sodium ingredients for the food service sector. Consumers are also encouraged to choose low sodium options, or use less salt in their home cooking. This sodium reduction strategy aims to reduce Singaporeans’ sodium intake by 15% by 2026.